Lipoprotein(a): A unique risk factor for cardiovascular disease

被引:75
作者
Anuurad, Erdembileg
Boffa, Michael B.
Koschinsky, Marlys L.
Berglund, Lars
机构
[1] Univ Calif Davis, Dept Med, VA No Calif Hlth Care Syst, Med Ctr, Sacramento, CA 95817 USA
[2] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
关键词
D O I
10.1016/j.cll.2006.07.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Lipoprotein(a) (Lp(a)) is present in humans and primates. It has many properties in common with low-density lipoprotein, but Qcontains a unique protein moiety designated apo(a), which is linked to apolipoprotein B-100 by a single disulfide bond. International standards for Lp(a) measurement and optimized Lp(a) assays insensitive to isoform size are not yet widely available. Lp(a) is a risk factor for coronary artery disease, and smaller size apo(a) is associated with coronary artery disease. The physiologic role of Lp(a) is unknown.
引用
收藏
页码:751 / +
页数:24
相关论文
共 129 条
[1]   LP(A) LIPOPROTEIN - RELATIONSHIP TO SINKING PRE-BETA LIPOPROTEIN, HYPERLIPOPROTEINEMIA, AND APOLIPOPROTEIN-B [J].
ALBERS, JJ ;
CABANA, VG ;
WARNICK, GR ;
HAZZARD, WR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (09) :1047-1054
[2]   Lp(a) lipoprotein, vascular disease, and mortality in the elderly [J].
Ariyo, AA ;
Thach, C ;
Tracy, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2108-2115
[3]   Electrophoretic measurement of lipoprotein(a) cholesterol in plasma with and without ultracentrifugation: comparison with an immunoturbidimetric lipoprotein(a) method [J].
Baudhuin, LM ;
Hartman, SJ ;
O'Brien, JF ;
Meissner, I ;
Galen, RS ;
Ward, JN ;
Hogen, SM ;
Branum, EL ;
McConnell, JP .
CLINICAL BIOCHEMISTRY, 2004, 37 (06) :481-488
[4]   LIPOPROTEIN(A) IN THE ARTERIAL-WALL [J].
BEISIEGEL, U ;
NIENDORF, A ;
WOLF, K ;
REBLIN, T ;
RATH, M .
EUROPEAN HEART JOURNAL, 1990, 11 :174-183
[5]  
BERG K, 1963, ACTA PATHOL MIC SC, V59, P369
[6]   Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet [J].
Berg, K ;
Svindland, A ;
Smith, AJ ;
Lawn, RM ;
Djurovic, S ;
Aleström, A ;
Aleström, P ;
Eliassen, K .
ATHEROSCLEROSIS, 2002, 163 (01) :99-104
[7]  
Berg K, 1997, CLIN GENET, V52, P254
[8]  
Berglund Lars, 1995, Current Opinion in Lipidology, V6, P48, DOI 10.1097/00041433-199502000-00011
[9]   Evidence for a role of phospholipid oxidation products in atherogenesis [J].
Berliner, JA ;
Subbanagounder, G ;
Leitinger, N ;
Watson, AD ;
Vora, D .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (3-4) :142-147
[10]   Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study [J].
Bostom, AG ;
Cupples, LA ;
Jenner, JL ;
Ordovas, JM ;
Seman, LJ ;
Wilson, PWF ;
Schaefer, EJ ;
Castelli, WP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07) :544-548